COGNITION THERAPEUTICS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Wallace Peggy | — | Purchase | 12,500 | $1.20 | $15,000 | 37,961 | Nov 15, 2022 |
| BIOS Fund I QP, LP | — | Purchase | 184,270 | $1.20 | $221,124 | 316,038 | Nov 15, 2022 |
| Cavu Management, LP | — | Purchase | 184,270 | $1.20 | $221,124 | 316,038 | Nov 15, 2022 |
| Golden Seeds Cognition Therapeutics LLC | — | Other | 2,489,682 | — | — | — | Sep 27, 2022 |
| Wallace Peggy | — | Other | 22,461 | — | — | 25,461 | Sep 27, 2022 |
| BIOS Memory SPV I, LP | — | C | 1,424,014 | — | — | 1,424,014 | Oct 13, 2021 |
| Fletcher Aaron G.L. | — | C | 1,424,014 | — | — | 1,424,014 | Oct 13, 2021 |
| Wallace Peggy | — | Purchase | 3,000 | $12.00 | $36,000 | 3,000 | Oct 13, 2021 |
| BIOS Memory SPV I, LP | — | Purchase | 144,530 | $12.00 | $1,734,360 | 899,905 | Oct 13, 2021 |
| Fletcher Aaron G.L. | — | Purchase | 144,530 | $12.00 | $1,734,360 | 899,905 | Oct 13, 2021 |
| Golden Seeds Cognition Therapeutics LLC | — | C | 311,706 | — | — | 2,489,691 | Oct 13, 2021 |
| Ogden CAP Associates, LLC | — | Sale | 74 | $12.00 | $889 | 2,210,377 | Oct 13, 2021 |
| Breedlove Mark H. | — | C | 44,806 | — | — | 44,806 | Oct 13, 2021 |
| Ricciardi Lisa | CEO & President | Purchase | 12,500 | $12.00 | $150,000 | 12,500 | Oct 13, 2021 |
| O'Brien James Michael | Chief Financial Officer | Purchase | 5,000 | $12.00 | $60,000 | 5,000 | Oct 13, 2021 |